Fat mass deposition during pregnancy using a four-component model.

Estimates of body fat mass gained during human pregnancy are necessary to assess the composition of gestational weight gained and in studying energy requirements of reproduction. However, commonly used methods of measuring body composition are not valid during pregnancy. We used measurements of total body water (TBW), body density, and bone mineral content (BMC) to apply a four-component model to measure body fat gained in nine pregnant women. Measurements were made longitudinally from before conception; at 8-10, 24-26, and 34-36 wk gestation; and at 4-6 wk postpartum. TBW was measured by deuterium dilution, body density by hydrodensitometry, and BMC by dual-energy X-ray absorptiometry. Body protein was estimated by subtracting TBW and BMC from fat-free mass. By 36 wk of gestation, body weight increased 11.2 +/- 4.4 kg, TBW increased 5.6 +/- 3.3 kg, fat-free mass increased 6.5 +/- 3.4 kg, and fat mass increased 4.1 +/- 3.5 kg. The estimated energy cost of fat mass gained averaged 44,608 kcal (95% confidence interval, -31, 552-120,768 kcal). The large variability in the composition of gestational weight gained among the women was not explained by prepregnancy body composition or by energy intake. This variability makes it impossible to derive a single value for the energy cost of fat deposition to use in estimating the energy requirement of pregnancy.     

Biological control of rice sheath blight using hyphae-associated bacteria: development of an <Emphasis Type="Italic">in planta</Emphasis> screening assay to predict biological control agent performance under field conditions

A pathogenicity assay for in planta screening of biological control agents (BCAs) towards sheath blight in rice was developed, and used to evaluate a panel of Rhizoctonia solani Kühn hyphae-associated bacteria for their ability to control sheath blight under screenhouse conditions. The best performing BCA, Burkholderia sp. strain A-7.3, was selected for field trials. Disease incidence and disease severity were significantly reduced leading to a significant grain yield increase of 7%. Furthermore, R. solani sclerotia formation and sclerotia viability were significantly reduced, thus lowering the reservoir for primary infections in the next crop cycle. The paper presents a reliable pathogenicity assay that can be used to test BCA performance under different scenarios e.g. plant variety and soil conditions, and help predict translation of results obtained under screenhouse conditions to field performance. Furthermore, it supports the hypothesis that hyphae-associated bacteria are a promising source of niche-specific BCAs towards fungal pathogens.     

A review of haliday species ofMicroctonus [Hym.: Braconidae,Euphorinae]

A neotype based on aWesmael specimen is designated forMicroctonus aethiops (Nees).M. aethiops of authors is described asaethiopoides, new species. Lectotypes are designated forM. secalis (Haliday) andcerealium (Haliday). The namecerealium is suppressed as a synonym of the namesecalis and the types ofsecalis andbrevicollis (Haliday) are redescribed.     

Correlation of cytotoxicity with experimental allergic encephalomyelitis.

Cytotoxicity of immune lymph node cells in experimental allergic encephalomyelitis (EAE) was maximal 9 days after injection of encephalitogenic emulsion. The ability of these cells to passively transfer EAE was also maximal at this time. Immune spleen cells were more cytotoxic than lymph node cells 9 days after injection; however, these cells did not passively transfer EAE. Twelve days after injection of encephalitogenic emulsion immune spleen cells passively transferred EAE with resulting mild histopathologic lesions. At this time the spleen cells were 50% more cytotoxic than comparable lymph node cells. Cyclophosphamide suppressed the development of clinical EAE and the development of cytotoxic lymphoid cells. It also reduced clinical signs and cytotoxic activity of lymph node cells. Spleen cell cytotoxic activity was enhanced by Cyclophosphamide. It was concluded that cytotoxic activity of lymph node and spleen cells was correlated with the ability of these cells to produce EAE. Lymph node cell populations differed qualitatively and/or quantitatively from immune spleen cell populations in EAE. Capacity to passively transfer EAE coincided with the maximal Cytotoxicity of the lymphoid cells from each tissue.     

大菜粉蝶颗粒体病毒的研究:包含体结合的碱性蛋白酶

本文报道从新疆分离的一株大菜粉蝶(Pieris brassicae)颗粒体病毒(PbGV)包含体上结合有碱性蛋白酶.提取含酶的包含体蛋白,以酪蛋白为底物鉴定表明此酶在pH9.4有最大的酶活力,并定位于“包裹”在病毒粒子套膜外的包含体蛋白中.在高pH时分子皿为26,500的包含体蛋白被酶降解为19,500和15,600道尔顿的两个组分.Hg⁺⁺、Cu⁺⁺仅部分抑制酶活力,可被二异丙基氟磷酸(DFP)完全抑制.75℃以上加热处理可使酶失活,并大大降低病毒包含体的解离.推测此酶是影响PbGV对寄主感染率的因子之一.     

β-蝮蛇毒素对蟾蜍交感神经节突触传递的影响

β-蝮蛇毒素(β-agkistrodotoxin简写β-AgTX)对骨胳肌神经肌肉接头的作用已有实验分析,本文则观察了β-AgTX对蟾蜍交感神经节胆碱能性和非胆碱能性突触电位的作用。结果表明,β-AgTX对胆碱能性快兴奋性突触后电位(f-EPSP)和由压力微量注射ACh产生的ACh电位快成分有可逆性抑制作用,且对f-EPSP的幅值抑制率明显大于对ACh电位的抑制率,方差分析显示β-AgTX对f-EPSP和对ACh电位的抑制之间的差异显著(P<0.01)。β-AgTX对非胆碱能性迟慢兴奋性突触后电位(1s-EPSP)无明显作用。本结果提示β-AgTX可能是通过抑制节前神经末梢释放AGh的突触前机制和占据突触后N型胆碱能受体影响ACh的作用之突触后机制,抑制蟾蜍交感神经节的胆碱能性传递过程。     

Receptor Complementation and Mutagenesis Reveal SR-BI as an Essential HCV Entry Factor and Functionally Imply Its Intra- and Extra-Cellular Domains

HCV entry into cells is a multi-step and slow process. It is believed that the initial capture of HCV particles by glycosaminoglycans and/or lipoprotein receptors is followed by coordinated interactions with the scavenger receptor class B type I (SR-BI), a major receptor of high-density lipoprotein (HDL), the CD81 tetraspanin, and the tight junction protein Claudin-1, ultimately leading to uptake and cellular penetration of HCV via low-pH endosomes. Several reports have indicated that HDL promotes HCV entry through interaction with SR-BI. This pathway remains largely elusive, although it was shown that HDL neither associates with HCV particles nor modulates HCV binding to SR-BI. In contrast to CD81 and Claudin-1, the importance of SR-BI has only been addressed indirectly because of lack of cells in which functional complementation assays with mutant receptors could be performed. Here we identified for the first time two cell types that supported HCVpp and HCVcc entry upon ectopic SR-BI expression. Remarkably, the undetectable expression of SR-BI in rat hepatoma cells allowed unambiguous investigation of human SR-BI functions during HCV entry. By expressing different SR-BI mutants in either cell line, our results revealed features of SR-BI intracellular domains that influence HCV infectivity without affecting receptor binding and stimulation of HCV entry induced by HDL/SR-BI interaction. Conversely, we identified positions of SR-BI ectodomain that, by altering HCV binding, inhibit entry. Finally, we characterized alternative ectodomain determinants that, by reducing SR-BI cholesterol uptake and efflux functions, abolish HDL-mediated infection-enhancement. Altogether, we demonstrate that SR-BI is an essential HCV entry factor. Moreover, our results highlight specific SR-BI determinants required during HCV entry and physiological lipid transfer functions hijacked by HCV to favor infection.